A random-control study of PMMA membrane as a filtrating agent of ascites in cell-free and concentrated ascites rein fusion therapy (CART) against patients with refractory ascites - A random-control study of CART using PMMA membrane against patients with refractory ascites

Third Department of Internal Medicine, Nara Medical University0 个研究点目标入组 20 人开始时间: 2018年2月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with heart disease corresponding to the following a) Patients with NYHA class 3 or higher congestive heart failure b) Patients with poorly controlled hypertension 2) Patients with severe and active infections (excluding HBV and HCV) 3) Patients with history of HIV infection 4) Patients during hemodialysis 5) Patients with portal vein tumor plugs with Vp3 or more 6) Patients with hepatic encephalopathy who are difficult to properly hydrate 7) Patients who had gastrointestinal bleeding which clinically becomes problem within 4 weeks before the start of the study 8) Patients who received treatment corresponding to the following a) Systemic chemotherapy b) Invasive surgery within 4 weeks before the start of the study 9) Pregnant women Patients who have a possibility or intent during lactation and pregnancy 10) Patients who may have an allergic reaction to this test device 11) Health condition, psychological state, social situation that interferes with substance abuse, participation in this study and evaluation of results Patient involved 12) In addition, if there is a possibility of impairing patient safety in conducting this examination, or When it is judged that compliance is difficult

发起方

Third Department of Internal Medicine, Nara Medical University